AXATILIMAB
Drug Details
- Generic Name
- AXATILIMAB
- Brand Names
- N/A
- Application Number
- Sponsor
- AGC Biologics, Inc.
- NDC Codes
- 1
- Dosage Forms
- SOLUTION
- Routes
- N/A
- Active Ingredients
- AXATILIMAB
Indications and Usage
1 INDICATIONS AND USAGE NIKTIMVO is indicated for the treatment of chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg. NIKTIMVO is a colony stimulating factor-1 receptor (CSF-1R)-blocking antibody indicated for the treatment of chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg. ( 1 )